Barrett's esophagus: Proton pump inhibitors and chemoprevention II

Joel E. Richter; Roberto Penagini; Daniel Pohl; Katerina Dvorak; Aaron Goldman; Edoardo Savarino; Patrizia Zentilin; Vincenzo Savarino; Joshua T. Watson; Roy K H Wong; Fabio Pace; Valentina Casini; David A. Peura; Shoshana Joy Herzig; Takeshi Kamiya; Iva Pelosini; Carmelo Scarpignato; David Armstrong; Kenneth R. Devault; Paolo Bechi; Antonio Taddei; Giancarlo Freschi; Maria Novella Ringressi; Duccio Rossi Degli'Innocenti; Francesca Castiglione; Emmanuella Masini; Richard H. Hunt

doi:10.1111/j.1749-6632.2011.06048.x

Barrett's esophagus: Proton pump inhibitors and chemoprevention II

Joel E. Richter, Roberto Penagini, Daniel Pohl, Katerina Dvorak, Aaron Goldman, Edoardo Savarino, Patrizia Zentilin, Vincenzo Savarino, Joshua T. Watson, Roy K H Wong, Fabio Pace, Valentina Casini, David A. Peura, Shoshana Joy Herzig, Takeshi Kamiya, Iva Pelosini, Carmelo Scarpignato, David Armstrong, Kenneth R. Devault, Paolo BechiAntonio Taddei, Giancarlo Freschi, Maria Novella Ringressi, Duccio Rossi Degli'Innocenti, Francesca Castiglione, Emmanuella Masini, Richard H. Hunt

Research output: Contribution to journal › Article › peer-review

Abstract

The following on proton pump inhibitors (PPIs) and chemoprevention in relation to Barrett's esophagus includes commentaries on 48-h pH monitoring, pH-impedence, bile acid testing, dyspepsia, long/short segment Barrett's esophagus, nonerosive reflux disease (NERD), functional heartburn, dual-release delivery PPIs, immediate-release PPIs, long-term PPI use, prokinetic agents, obesity, baclofen, nocturnal acid breakthrough, nonsteroidal anti-inflammatory drugs (NSAIDs), and new PPIs.

Original language	English
Pages (from-to)	114-139
Number of pages	26
Journal	Annals of the New York Academy of Sciences
Volume	1232
Issue number	1
DOIs	https://doi.org/10.1111/j.1749-6632.2011.06048.x
Publication status	Published - Sep 2011

Keywords

48-h acid reflux monitoring
ACG guidelines
Acid suppression
API-023
AspECT trial
Baclofen
Barrett's esophagus
Bile acids
Bilitec probe
Clostridium difficile
CMA omeprazole
COX-2 inhibitors
Dexlansoprazole
Erosive esophigitis
Functional dyspepsia
Functional heartburn
Fundic glands polyp
GABA
GERD
Ilaprazole
NERD
Nocturnal acid breakthrough
PH testing
Pharmacokinetic changes
PPI therapy
Rabeprazole
STU-Na
Symptom Association Probability
Tenatoprazole
TLESR

ASJC Scopus subject areas

Biochemistry, Genetics and Molecular Biology(all)
History and Philosophy of Science

Access to Document

10.1111/j.1749-6632.2011.06048.x

Cite this

Richter, J. E., Penagini, R., Pohl, D., Dvorak, K., Goldman, A., Savarino, E., Zentilin, P., Savarino, V., Watson, J. T., Wong, R. K. H., Pace, F., Casini, V., Peura, D. A., Herzig, S. J., Kamiya, T., Pelosini, I., Scarpignato, C., Armstrong, D., Devault, K. R., ... Hunt, R. H. (2011). Barrett's esophagus: Proton pump inhibitors and chemoprevention II. Annals of the New York Academy of Sciences, 1232(1), 114-139. https://doi.org/10.1111/j.1749-6632.2011.06048.x

Barrett's esophagus : Proton pump inhibitors and chemoprevention II. / Richter, Joel E.; Penagini, Roberto; Pohl, Daniel; Dvorak, Katerina; Goldman, Aaron; Savarino, Edoardo; Zentilin, Patrizia; Savarino, Vincenzo; Watson, Joshua T.; Wong, Roy K H; Pace, Fabio; Casini, Valentina; Peura, David A.; Herzig, Shoshana Joy; Kamiya, Takeshi; Pelosini, Iva; Scarpignato, Carmelo; Armstrong, David; Devault, Kenneth R.; Bechi, Paolo; Taddei, Antonio; Freschi, Giancarlo; Ringressi, Maria Novella; Degli'Innocenti, Duccio Rossi; Castiglione, Francesca; Masini, Emmanuella; Hunt, Richard H.

In: Annals of the New York Academy of Sciences, Vol. 1232, No. 1, 09.2011, p. 114-139.

Research output: Contribution to journal › Article › peer-review

Richter, JE, Penagini, R, Pohl, D, Dvorak, K, Goldman, A, Savarino, E, Zentilin, P, Savarino, V, Watson, JT, Wong, RKH, Pace, F, Casini, V, Peura, DA, Herzig, SJ, Kamiya, T, Pelosini, I, Scarpignato, C, Armstrong, D, Devault, KR, Bechi, P, Taddei, A, Freschi, G, Ringressi, MN, Degli'Innocenti, DR, Castiglione, F, Masini, E & Hunt, RH 2011, 'Barrett's esophagus: Proton pump inhibitors and chemoprevention II', Annals of the New York Academy of Sciences, vol. 1232, no. 1, pp. 114-139. https://doi.org/10.1111/j.1749-6632.2011.06048.x

Richter, Joel E. ; Penagini, Roberto ; Pohl, Daniel ; Dvorak, Katerina ; Goldman, Aaron ; Savarino, Edoardo ; Zentilin, Patrizia ; Savarino, Vincenzo ; Watson, Joshua T. ; Wong, Roy K H ; Pace, Fabio ; Casini, Valentina ; Peura, David A. ; Herzig, Shoshana Joy ; Kamiya, Takeshi ; Pelosini, Iva ; Scarpignato, Carmelo ; Armstrong, David ; Devault, Kenneth R. ; Bechi, Paolo ; Taddei, Antonio ; Freschi, Giancarlo ; Ringressi, Maria Novella ; Degli'Innocenti, Duccio Rossi ; Castiglione, Francesca ; Masini, Emmanuella ; Hunt, Richard H. / Barrett's esophagus : Proton pump inhibitors and chemoprevention II. In: Annals of the New York Academy of Sciences. 2011 ; Vol. 1232, No. 1. pp. 114-139.

@article{a9102d036f3945cb8f44c2938a45c33b,

title = "Barrett's esophagus: Proton pump inhibitors and chemoprevention II",

abstract = "The following on proton pump inhibitors (PPIs) and chemoprevention in relation to Barrett's esophagus includes commentaries on 48-h pH monitoring, pH-impedence, bile acid testing, dyspepsia, long/short segment Barrett's esophagus, nonerosive reflux disease (NERD), functional heartburn, dual-release delivery PPIs, immediate-release PPIs, long-term PPI use, prokinetic agents, obesity, baclofen, nocturnal acid breakthrough, nonsteroidal anti-inflammatory drugs (NSAIDs), and new PPIs.",

keywords = "48-h acid reflux monitoring, ACG guidelines, Acid suppression, API-023, AspECT trial, Baclofen, Barrett's esophagus, Bile acids, Bilitec probe, Clostridium difficile, CMA omeprazole, COX-2 inhibitors, Dexlansoprazole, Erosive esophigitis, Functional dyspepsia, Functional heartburn, Fundic glands polyp, GABA, GERD, Ilaprazole, NERD, Nocturnal acid breakthrough, PH testing, Pharmacokinetic changes, PPI therapy, Rabeprazole, STU-Na, Symptom Association Probability, Tenatoprazole, TLESR",

author = "Richter, {Joel E.} and Roberto Penagini and Daniel Pohl and Katerina Dvorak and Aaron Goldman and Edoardo Savarino and Patrizia Zentilin and Vincenzo Savarino and Watson, {Joshua T.} and Wong, {Roy K H} and Fabio Pace and Valentina Casini and Peura, {David A.} and Herzig, {Shoshana Joy} and Takeshi Kamiya and Iva Pelosini and Carmelo Scarpignato and David Armstrong and Devault, {Kenneth R.} and Paolo Bechi and Antonio Taddei and Giancarlo Freschi and Ringressi, {Maria Novella} and Degli'Innocenti, {Duccio Rossi} and Francesca Castiglione and Emmanuella Masini and Hunt, {Richard H.}",

year = "2011",

month = sep,

doi = "10.1111/j.1749-6632.2011.06048.x",

language = "English",

volume = "1232",

pages = "114--139",

journal = "Annals of the New York Academy of Sciences",

issn = "0077-8923",

publisher = "Wiley-Blackwell",

number = "1",

}

TY - JOUR

T1 - Barrett's esophagus

T2 - Proton pump inhibitors and chemoprevention II

AU - Richter, Joel E.

AU - Penagini, Roberto

AU - Pohl, Daniel

AU - Dvorak, Katerina

AU - Goldman, Aaron

AU - Savarino, Edoardo

AU - Zentilin, Patrizia

AU - Savarino, Vincenzo

AU - Watson, Joshua T.

AU - Wong, Roy K H

AU - Pace, Fabio

AU - Casini, Valentina

AU - Peura, David A.

AU - Herzig, Shoshana Joy

AU - Kamiya, Takeshi

AU - Pelosini, Iva

AU - Scarpignato, Carmelo

AU - Armstrong, David

AU - Devault, Kenneth R.

AU - Bechi, Paolo

AU - Taddei, Antonio

AU - Freschi, Giancarlo

AU - Ringressi, Maria Novella

AU - Degli'Innocenti, Duccio Rossi

AU - Castiglione, Francesca

AU - Masini, Emmanuella

AU - Hunt, Richard H.

PY - 2011/9

Y1 - 2011/9

N2 - The following on proton pump inhibitors (PPIs) and chemoprevention in relation to Barrett's esophagus includes commentaries on 48-h pH monitoring, pH-impedence, bile acid testing, dyspepsia, long/short segment Barrett's esophagus, nonerosive reflux disease (NERD), functional heartburn, dual-release delivery PPIs, immediate-release PPIs, long-term PPI use, prokinetic agents, obesity, baclofen, nocturnal acid breakthrough, nonsteroidal anti-inflammatory drugs (NSAIDs), and new PPIs.

AB - The following on proton pump inhibitors (PPIs) and chemoprevention in relation to Barrett's esophagus includes commentaries on 48-h pH monitoring, pH-impedence, bile acid testing, dyspepsia, long/short segment Barrett's esophagus, nonerosive reflux disease (NERD), functional heartburn, dual-release delivery PPIs, immediate-release PPIs, long-term PPI use, prokinetic agents, obesity, baclofen, nocturnal acid breakthrough, nonsteroidal anti-inflammatory drugs (NSAIDs), and new PPIs.

KW - 48-h acid reflux monitoring

KW - ACG guidelines

KW - Acid suppression

KW - API-023

KW - AspECT trial

KW - Baclofen

KW - Barrett's esophagus

KW - Bile acids

KW - Bilitec probe

KW - Clostridium difficile

KW - CMA omeprazole

KW - COX-2 inhibitors

KW - Dexlansoprazole

KW - Erosive esophigitis

KW - Functional dyspepsia

KW - Functional heartburn

KW - Fundic glands polyp

KW - GABA

KW - GERD

KW - Ilaprazole

KW - NERD

KW - Nocturnal acid breakthrough

KW - PH testing

KW - Pharmacokinetic changes

KW - PPI therapy

KW - Rabeprazole

KW - STU-Na

KW - Symptom Association Probability

KW - Tenatoprazole

KW - TLESR

UR - http://www.scopus.com/inward/record.url?scp=80053198166&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80053198166&partnerID=8YFLogxK

U2 - 10.1111/j.1749-6632.2011.06048.x

DO - 10.1111/j.1749-6632.2011.06048.x

M3 - Article

C2 - 21950810

AN - SCOPUS:80053198166

VL - 1232

SP - 114

EP - 139

JO - Annals of the New York Academy of Sciences

JF - Annals of the New York Academy of Sciences

SN - 0077-8923

IS - 1

ER -

Barrett's esophagus: Proton pump inhibitors and chemoprevention II

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this